Finally, our studies suggest that therapeutic agents that maintain Mac-1 allosterically in a bent state may be able to control the deleterious effects of FcγRIIA mediated neutrophil accumulation in autoimmune disease. Here, ITGB2 is linked to autoimmune disease.